A first-of-its-kind study examines the differing effects of sucrose versus glucose intake on circulating glucagon-like peptide-1 (GLP-1).
Read More »High-Intensity Interval Training and Type 1 Diabetes: Effect on Glycemic Control
Does a 12-week high-intensity interval training (HIIT) program show superior glucose control in type 1 diabetes than other forms of exercise?
Read More »Oral Health and Diabetes Complications
Better oral health may be linked to better outcomes in patients with diabetes, but which comes first -- gum disease or diabetes?
Read More »Can Blood Pressure Control Lower the Risk of Dementia Development?
Lowering patients' blood pressure could save their brains.
Read More »Diabetes as a Predictor of Myocardial Infarction Occurrence and Outcomes
An analysis of over three million patients assessed the impact of diabetes on in-hospital mortality after myocardial infarction.
Read More »How to Address Those Nagging Joint Injuries and Pain
By Sheri Colberg, PhD
In late 2017, one of my columns addressed whether you can determine if your joint issues are related to being active, normal aging, or diabetes. The answer was that you really couldn't determine the exact cause(s), but any or all of them may be contributors. Does it matter more if you know the underlying cause if you can figure out the best treatment?
Always Reevaluate Background Therapies When Starting a New Glucose-Lowering Agent
We were asked to consult on a case involving BK, a 74-year-old man with type 2 diabetes (T2D) of 12 years duration. He was a retired restaurant manager who lived with his wife of 52 years. BK had a positive history of tobacco smoking (2 packs per day for 35 years), but he quit ten years ago following his grandson's birth. He monitors his blood glucose level two to three times daily....
Read More »Risk Associated with Insulin Dose Before Exercising
A small pilot study investigates how modest hyperglycemia, not hyperinsulinemia, is better for people with type 1 diabetes during exercise.
Read More »Canagliflozin Effects on Heart Failure and Cardiovascular Death
Canaglifozin reduced risk of cardiovascular death and hospitalizations due to heart failure by 31%.
Read More »Better Prevention/Treatment for Diabetic Kidney Disease in T2D
Are you doing everything you can to ensure your patient has the best quality of life possible with type 2 diabetes?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.